Results 171 to 180 of about 24,935 (185)

Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802

Clinical Pharmacokinetics, 2012
Penelope Ward
exaly  

Simultaneous quantification of prodrug oseltamivir and its metabolite oseltamivir carboxylate in human plasma by LC–MS/MS to support a bioequivalence study

Journal of Pharmaceutical Analysis, 2013
Mallika Sanyal, Pranav Shrivastav, Swati Guttikar   +2 more
exaly  

Oseltamivir

Reactions Weekly, 2017
openaire   +1 more source

Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation

Drug Delivery, 2015
Jianping Liu, Xinyuan Xi
exaly  

Analysis of oseltamivir active metabolite, oseltamivir carboxylate, in biological materials by HPLC-UV in a case of death following ingestion of Tamiflu®

Legal Medicine, 2008
Yoko Ihama, Chiaki Fuke, Tetsuji Miyazaki   +2 more
exaly  

Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors

Carbohydrate Research, 2019
Yu Peng, Kui Lu, Yang Yang
exaly  

Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects

Journal of Clinical Pharmacology, 2007
exaly  

High‐Yielding Synthesis of the Anti‐Influenza Neuramidase Inhibitor (−)‐Oseltamivir by Three “One‐Pot” Operations

Angewandte Chemie - International Edition, 2009
Yujiro Hayashi, Hayato Ishikawa
exaly  

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

Lancet, The, 2004
Yoshihiro Kawaoka, Frederick Hayden, Yuko Sakai-Tagawa   +2 more
exaly  

Pharmacokinetics of oseltamivir in breast milk and maternal plasma

American Journal of Obstetrics and Gynecology, 2011
Scott W Roberts, George D Wendel, Jeanne S Sheffield   +2 more
exaly